Profile for European Patent Office Patent: 1591122
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2013 00016 | ⤷ Start Trial |
| Netherlands | C300582 | ⤷ Start Trial |
| Luxembourg | 92174 | ⤷ Start Trial |
| Switzerland | C01591122/01 | ⤷ Start Trial |
| Netherlands | 300582 | ⤷ Start Trial |
| Germany | 122013000031 | ⤷ Start Trial |
| Belgium | 2013C/022 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1591122
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
